Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Lex Eggermont, S Suciu, R MacKie, W Ruka, A Testori, Wim Kruit, CJA Punt, M Delauney, F Sales, G Groenewegen, DJ Ruiter, I Jagiello, K Stoitchkov, U Keilholz, D Lienard

Research output: Contribution to journalArticleAcademicpeer-review

302 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1189-1196
Number of pages8
JournalLancet (UK)
Volume366
Issue number9492
DOIs
Publication statusPublished - 2005

Research programs

  • EMC MM-03-47-11
  • EMC MM-03-86-12

Cite this